Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer
This study is not yet open for participant recruitment.
Verified May 2013 by Duke University
Sponsor:
Duke University
Collaborator:
Janssen Pharmaceuticals
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT01717053
First received: October 26, 2012
Last updated: May 3, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | September 2016 |
| Estimated Primary Completion Date: | September 2015 (Final data collection date for primary outcome measure) |